SCHEMBL19088280

SCHEMBL19088280

COc1ccc(Cl)cc1OC(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.46
PDE4B Q07343 2/20 0.46
GAA P10253 1/20 0.44
SLC9A1 P19634 1/20 0.44
CSNK2A1 P68400 2/20 0.43
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
ALDH1A1 P00352 4/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
CYP2D6 P10635 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2127233 0.83 TRPV4 (0.55) TRPV4GAAHTR3EHTR3BHTR3A
SCHEMBL29636402 0.83 TRPV4 (0.55) TRPV4GAAHTR3EHTR3BHTR3A
SCHEMBL3427498 0.82 NQO1 (0.40) TRPV4GAASLC9A1CSNK2A1ALDH1A1
SCHEMBL28298273 0.81 TRPV4 (0.53) TRPV4GAAHTR3EHTR3BHTR3A
SCHEMBL17744335 0.80 HSD17B10 (0.45) GAASLC9A1CSNK2A1ALDH1A1SLC6A2
SCHEMBL14601308 0.79 TTR (0.53) CSNK2A1SLC6A2SLC6A4SLC6A3MAPT
SCHEMBL24305883 0.79 SLC6A2 (0.46) TRPV4HTR3EHTR3BHTR3AHTR3D
SCHEMBL11223797 0.79 NOS2 (0.49) GAACSNK2A1ALDH1A1SLC6A2SLC6A4
SCHEMBL7172382 0.79 CSNK2A1 (0.59) GAACSNK2A1ALDH1A1SLC6A2SLC6A3
SCHEMBL25974456 0.78 HTR2A (0.46) CSNK2A1SLC6A4MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119351-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2022-04-21 US disclosed
WO-2020223136-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2020-11-05 WO disclosed
WO-2017117406-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF Karyopharm Therapeutics Inc. (US) 2017-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119351-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA5, CHRNA2 TRPV4 811/4885PDE4B 111/4885GAA 1838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.